Moreover, size effects and surface modifications, including platelet membrane mimicry and HER2‐targeted peptides, enable selective tumor accumulation and localized drug delivery, maximizing efficacy while minimizing toxicity. This evidence concerns the gene ERBB2 and neoplasm.